Diabetes :: Study highlights characteristics of patients with type 2 diabetes initiating insulin
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) and Eli Lilly and Company (NYSE: LLY) announced baseline data from INSTIGATE, a 24-month study presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam, The Netherlands.